HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Okamoto Selected Research

Temozolomide (Temodar)

5/2019Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy.
9/2011Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas.
6/2010Gene expression profiling predicts response to temozolomide in malignant gliomas.
7/2009Effect of IFN-beta on human glioma cell lines with temozolomide resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Okamoto Research Topics

Disease

5Glioma (Gliomas)
02/2018 - 07/2009
3Glioblastoma (Glioblastoma Multiforme)
02/2018 - 09/2011
2Eye Infections
09/2011 - 09/2011
2Neoplasms (Cancer)
06/2010 - 07/2009
1Skin Neoplasms (Skin Cancer)
05/2019
1Melanoma (Melanoma, Malignant)
05/2019
1Neoplasm Metastasis (Metastasis)
05/2019
1Chronic Hepatitis C
02/2018
1Pancreatic Diseases (Pancreatic Disease)
02/2016
1Pathologic Constriction (Stenosis)
02/2016
1Infections
12/2014
1Brain Neoplasms (Brain Tumor)
09/2011
1Hepatitis B
02/2007
1Hepatitis
02/2007
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2007

Drug/Important Bio-Agent (IBA)

4Temozolomide (Temodar)FDA LinkGeneric
05/2019 - 07/2009
4InterferonsIBA
05/2019 - 09/2011
3Alkylating AgentsIBA
09/2011 - 07/2009
2Proteins (Proteins, Gene)FDA Link
02/2018 - 06/2010
2Ribavirin (Virazole)FDA LinkGeneric
02/2018 - 12/2014
2DNA (Deoxyribonucleic Acid)IBA
09/2011 - 02/2007
2Pharmaceutical PreparationsIBA
09/2011 - 09/2011
1Ataxia Telangiectasia Mutated ProteinsIBA
02/2018
1Antiviral Agents (Antivirals)IBA
02/2018
1Nucleic AcidsIBA
02/2018
1RNA (Ribonucleic Acid)IBA
02/2018
1CaspasesIBA
02/2018
1OligonucleotidesIBA
12/2014
1NucleotidesIBA
09/2011
1FluoroquinolonesIBA
09/2011
1Messenger RNA (mRNA)IBA
06/2010
1Complementary DNA (cDNA)IBA
06/2010
1Surface Antigens (Surface Antigen)IBA
02/2007
1Rituximab (Mabthera)FDA Link
02/2007

Therapy/Procedure

4Therapeutics
05/2019 - 06/2010
4Drug Therapy (Chemotherapy)
05/2019 - 02/2007
1Self Expandable Metallic Stents
02/2016